VCPlus Limited announced cessation of Mr. Chua Ser Miang as Non-Executive Chairman and Lead Independent Director, Chairman of RC and member of AC and NC. Other DirectorShips Past: China Knowledge Data Technology Pte. Ltd. Eastwin Capital Pte.

Ltd. Yamada Green Resources Limited. Other DirectorShips Present: Acumen Diagnostics Pte. Ltd. Acumen Research Laboratories Pte.

Ltd. Aoxin Q&M Dental Group Limited LS 2 Holdings Limited. Reason For Cessation: Mr. Chua Ser Miang was appointed as an Independent Director of the Company on 29 December 2020 and was last re-elected as Director on 29 April 2022. In accordance with Regulation 114 of the Company's Constitution, Mr. Chua was due for retirement by rotation at the upcoming annual general meeting to be held on 26 April 2024.

In view of the Company's recent embarkment upon new services pursuant to a joint venture as announced by the Company on 31 March 2024 with a new management led by shareholder and Executive Director Ms. Tang Zhengming; the appointment of new independent director, Mr. Ong Choon Yi and non-executive director, Mr. Thomas Pai who collectively have the relevant expertise including experience with the new services spearheaded by Ms. Tang; and the process already put in motion for the recruitment of additional director(s) to further enhance board diversity of skills, knowledge and experience, Mr. Chua was of the view that it is now timely to retire as Independent Director of the Company for the rejuvenation and refreshment of its board of directors. Accordingly, Mr. Chua will not be seeking re-appointment and will cease to be a Director of the Company after the conclusion of the AGM. Based on its enquiries, the Company's sponsor, UOB Kay Hian Private Limited, is satisfied that, save as disclosed in the announcement, there are no other material reasons for the cessation of Mr. Chua as the Independent Director of the Company.